In the dynamic world of herbal extract manufacturing, the quest for enhancing therapeutic benefits has led to a profound exploration of modified bioavailability. As manufacturers, understanding and harnessing the potential of modified bioavailability can be a game-changer, unlocking new possibilities for delivering maximum therapeutic impact.
As herbal extract manufacturers, embracing and mastering modified bioavailability is not just a trend; it’s a strategic imperative for ensuring that your products deliver the maximum therapeutic benefits that consumers demand in the evolving landscape of natural wellness.
Mprex is a leading CRO in nutraceutical research providing the most extensive, trustworthy, end-to-end human and animal studies for the bioavailability and pharmacokinetics of herbal extracts.
Mprex provides broad-spectrum research solutions like nutraceutical bioavailability studies, pharmacokinetic PK studies, preclinical, in vitro, and clinical studies for herbal and nutraceutical ingredients.
Pharmacokinetic (PK) study parameters include assessing how a drug is absorbed (bioavailability, time to peak concentration), distributed (volume of distribution, protein binding), metabolized (metabolic rate, half-life) and excreted (clearance, renal excretion). These parameters, such as area under the curve (AUC) and peak plasma concentration (Cmax), provide insights into the drug’s overall exposure in the body, guiding dosing strategies for optimal therapeutic outcomes, minimizing potential side effects and relating efficacy with doses.
BENEFITS
OUR CERTIFICATION
